Cosmetic Hair Growth Materials 99% Setipiprant Powder CAS 866460-33-5
Product Description
Setipiprant is a drug that has been studied for its potential use in treating hair loss, specifically androgenetic alopecia. It works as a selective antagonist of the prostaglandin D2 receptor, which is believed to play a role in the hair loss process. By blocking this receptor, setipiprant aims to counteract the effects of prostaglandin D2 and potentially promote hair growth.
COA
ITEMS | STANDARD | RESULTS |
Appearance | White Powder | Conform |
Odor | Characteristic | Conform |
Taste | Characteristic | Conform |
Assay | ≥99% | 99.76% |
Heavy Metals | ≤10ppm | Conform |
As | ≤0.2ppm | <0.2 ppm |
Pb | ≤0.2ppm | <0.2 ppm |
Cd | ≤0.1ppm | <0.1 ppm |
Hg | ≤0.1ppm | <0.1 ppm |
Total Plate Count | ≤1,000 CFU/g | <150 CFU/g |
Mold & Yeast | ≤50 CFU/g | <10 CFU/g |
E. Coll | ≤10 MPN/g | <10 MPN/g |
Salmonella | Negative | Not Detected |
Staphylococcus Aureus | Negative | Not Detected |
Conclusion | Conform to the specification of the requirement. | |
Storage | Store in a cool, dry and ventilated place place. | |
Shelf Life | Two years if sealed and store away from direct sun light and moisture. |
Function
Setipiprant is a drug that has been studied for its potential efficacy in treating hair loss, particularly androgenetic alopecia. Its proposed effects include:
1. Inhibition of Prostaglandin D2: Setipiprant works as a selective antagonist of the prostaglandin D2 receptor, aiming to counteract the effects of this prostaglandin, which is believed to be involved in the hair loss process.
2. Promotion of Hair Growth: By blocking the prostaglandin D2 receptor, setipiprant is intended to potentially promote hair growth and mitigate the progression of androgenetic alopecia.
Application
Setipiprant is being researched for its potential application in the treatment of androgenetic alopecia, which is a common form of hair loss. It is believed to work by targeting the prostaglandin D2 receptor, which may play a role in the hair loss process. By blocking this receptor, setipiprant aims to counteract the effects of prostaglandin D2 and potentially promote hair growth.